Abstract
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of oxygen homeostasis in all metazoan species. O2-dependent hydroxylation of two proline residues in the HIF-1α subunit is necessary for the binding of the von Hippel–Lindau (VHL) protein, which is a component of a ubiquitin protein ligase that ubiquitinates HIF-1α, leading to its degradation by the proteasome. In the majority of cases of the clear cell type of renal carcinoma, both VHL genes are inactivated by mutation or epigenetic silencing, leading to dysregulated HIF-1 transcriptional activity. VHL loss-of-function leads, under aerobic conditions, to a HIF-1-dependent reprogramming of glucose and energy metabolism that includes increased glucose uptake, glycolysis, and lactate production accompanied by a reciprocal decrease in respiration. These findings delineate for the first time the molecular mechanisms underlying the Warburg effect in a human cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bruick RK, McKnight SL (2001) Science 294:1337–1340
Carroll RC, Ash JF, Vogt PK, Singer SJ (1978) Proc Natl Acad Sci USA 75:5015–5019
Craven RA, Hanrahan S, Totty N, Harnden P, Stanley AJ, Maher ER, Harris AL, Trimble WS, Selby PJ, Banks RE (2006) Proteomics 6:3880–3893
Ebert BL, Firth JD, Ratcliffe PJ (1995) J Biol Chem 270:29083–29089
Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM (2006) J Biol Chem 281:15215–15226
Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O’Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ (2001) Cell 107:43–54
Firth JD, Ebert BL, Ratcliffe PJ (1995) J Biol Chem 270:21021–21027
Gatenby RA, Gillies RJ (2004) Nat Rev, Cancer 4:891–899
Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT (2005) Cell Metab 1:401–408
Hervouet E, Demont J, Pecina P, Vojtiskova A, Houstek J, Simonnet H, Godinot C (2005) Carcinogenesis 26:531–539
Hervouet E, Godinot C (2006) Mitochondrion 6:105–117
Hirota K, Semenza GL (2006) Crit Rev Oncol Hematol 59:15–26
Huang LE, Gu J, Schau M, Bunn HF (1998) Proc Natl Acad Sci USA 95:7987–7992
Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K, Yang H, Sorokina I, Conaway RC, Conaway JW, Kaelin WG Jr (2002) Proc Natl Acad Sci USA 99:13459–13464
Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr (2001) Science 292:464–468
Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL (1998) Genes Dev 12:149–162
Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim AV, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Science 292:468–472
Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M (2001) FASEB J 15:1312–1314
Jiang B-H, Semenza GL, Bauer C, Marti HH (1996) Am J Physiol 271:C1172–C1180
Kallio PJ, Wilson WJ, O’Brien S, Makino Y, Poellinger L (1999) J Biol Chem 274:6519–6525
Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC, Conaway JW (2000) Proc Natl Acad Sci USA 97:10430–10435
Kim J-W, Tchernyshyov I, Semenza GL, Dang CV (2006) Cell Metab 3:177–185
Lehninger AL (1982) Principles of biochemistry. Worth, New York
Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL (2005) Blood 105:659–669
Mandriota SJ, Turner KJ, Davies DR, Murray PG, Morgan NV, Sowter HM, Wykoff CC, Maher ER, Harris AL, Ratcliffe PJ, Maxwell PH (2002) Cancer Cell 1:459–468
Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher, ER, Ratcliffe PJ (1999) Nature 399:271–275
Meierhofer D, Mayr JA, Foetschl U, Berger A, Fink K, Schmeller N, Hacker GW, Hauser-Kronberger C, Kofler B, Sperl W (2004) Carcinogenesis 25:1005–1010
Motzer RJ, Bacik J, Mazumdar M (2004) Clin Cancer Res 10:6302S–6303S
Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) Cell Metab 3:187–197
Ryan HE, Lo J, Johnson RS (1998) EMBO J 17:3005–3015
Salceda S, Caro J (1997) J Biol Chem 272:22642–22647
Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, Laderoute K, Johnson RS (2001) Mol Cell Biol 21:3436–3444
Semenza GL (2003) Nat Rev Cancer 3:721–732
Semenza GL, Jiang B-H, Leung SW, Passantino R, Concordet J-P, Maire P, Giallongo A (1996) J Biol Chem 271:32529–32537
Semenza GL, Roth PH, Fang H-M, Wang GL (1994) J Biol Chem 269:23757–23763
Semenza GL, Wang GL (1992) Mol Cell Biol 12:5447–5454
Simonnet H, Alazard N, Pfeiffer K, Gallou C, Beroud C, Demont J, Bouvier R, Schagger H, Godinot C (2002) Carcinogenesis 23:759–768
Singh VN, Singh M, August JT, Horecker BL (1974) Proc Natl Acad Sci USA 71:4129–4132
Steck TL, Kaufman S, Bader JP (1968) Cancer Res 28:1611–1619
Tian H, McKnight SL, Russell DW (1997) Genes Dev 11:72–82
Unwin RD, Craven RA, Harnden P, Hanrahan S, Totty N, Knowles M, Eardley I, Selby PJ, Banks RE (2003) Proteomics 3:1620–1632
Wang GL, Jiang B-H, Rue EA, Semenza GL (1995) Proc Natl Acad Sci USA 92:5510–5514
Wang GL, Semenza GL (1995) J Biol Chem 270:1230–1237
Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ, Maxwell PH (1998) Blood 92:2260–2268
Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL (1998) Am J Physiol 275:L818–L826
Yu F, White SB, Zhao Q, Lee FS (2001) Proc Natl Acad Sci USA 98:9630–9635
Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, Dang CV, Semenza GL (2007) Cancer Cell 11:407–420
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Semenza, G.L. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 39, 231–234 (2007). https://doi.org/10.1007/s10863-007-9081-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-007-9081-2